International Organization of MS Nurses
Written by Administrator2
- ACUTE NEUROLOGIC ILLNESS WITH FOCAL LIMB WEAKNESS OF UNKNOWN ETIOLOGY IN CHILDREN
In September, the Centers for Disease Control and Prevention (CDC) issued a Health Advisory to healthcare professionals nationwide to be vigilant for and report cases of neurologic illnesses associated with limb weakness that meet the criteria of its case definition. Learn more.
- UPCOMING EVENTS - 2014
◦ MS TRUST ANNUAL CONFERENCE (Kenilworth, UK)
- PEGYLATED INTERFERON BETA-1A (PLEGRIDY) – CLINICIAN INFORMATION
Generic: Peginterferon Beta-1a
Brand name: Plegridy
US FDA Approved: August 2014
- MS COALITION: The Use of Disease-Modifying Therapies in MS
The member organizations of the Multiple Sclerosis Coalition have collaborated to summarize the current evidence about disease modification in multiple sclerosis (MS) and to provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people.
- Counseling Points: SUMMER 2014 Volume 10, Number 1
Management of MS Through the Life Stages
- MOVING FORWARD:
Adherence to Therapy & the Role of Nursing in MS
- WEBINAR: Caring for the Patient with MS
Please join us on Monday - October 20, 2014 at 8PM ET for another webinar on Caring for the Patient with MS. The discussion will focus on Symptomatic Management of MS: Invisible Symptoms and will be presented by :
Marie Moore, MSN, FNP-C, MSCN
Carolinas Medical System - MS Center
This event is awarded 1.0 CEU.
- iPointofCare: Managing Patients with MS
This is an innovative evidence-based, clinical resource for MS specialists, providing answers to clinical questions at or near the "point-of-care" - where and when clinicians need it: in the office, in the exam room, on computers, tablets or smart phones. All material is peer-reviewed and faculty-approved.
Release Date: January 25, 2013
Valid Through: January 30, 2015